These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 31513484)

  • 1. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
    Pietrantonio F; Miceli R; Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Morano F; Wotherspoon A; Valeri N; Kook MC; An JY; Grabsch HI; Fucà G; Noh SH; Sohn TS; Kim S; Di Bartolomeo M; Cunningham D; Lee J; Cheong JH; Smyth EC
    J Clin Oncol; 2019 Dec; 37(35):3392-3400. PubMed ID: 31513484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials.
    Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Randon G; Kook MC; An JY; Grabsch HI; Prisciandaro M; Nichetti F; Noh SH; Sohn TS; Kim S; Wotherspoon A; Morano F; Cunningham D; Lee J; Cheong JH; Smyth EC; Pietrantonio F
    Eur J Cancer; 2024 May; 203():114043. PubMed ID: 38598921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.
    Di Bartolomeo M; Morano F; Raimondi A; Miceli R; Corallo S; Tamborini E; Perrone F; Antista M; Niger M; Pellegrinelli A; Randon G; Pagani F; Martinetti A; Fucà G; Pietrantonio F;
    Oncologist; 2020 Mar; 25(3):e460-e468. PubMed ID: 32162808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy.
    Jiang D; Shu C; Zhang W; Sun L; Zhang M; He Y; Owen G; Jin W; He D; Deng X; Liu X
    Virchows Arch; 2021 Feb; 478(2):231-240. PubMed ID: 32588133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer.
    Kim JW; Cho SY; Chae J; Kim JW; Kim TY; Lee KW; Oh DY; Bang YJ; Im SA
    Cancer Res Treat; 2020 Oct; 52(4):1178-1187. PubMed ID: 32599979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
    Nie RC; Chen GM; Yuan SQ; Kim JW; Zhou J; Nie M; Feng CY; Chen YB; Chen S; Zhou ZW; Wang Y; Li YF
    Ann Surg Oncol; 2022 Apr; 29(4):2324-2331. PubMed ID: 34796431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.
    Smyth EC; Wotherspoon A; Peckitt C; Gonzalez D; Hulkki-Wilson S; Eltahir Z; Fassan M; Rugge M; Valeri N; Okines A; Hewish M; Allum W; Stenning S; Nankivell M; Langley R; Cunningham D
    JAMA Oncol; 2017 Sep; 3(9):1197-1203. PubMed ID: 28241187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
    Miceli R; An J; Di Bartolomeo M; Morano F; Kim ST; Park SH; Choi MG; Lee JH; Raimondi A; Fucà G; Sohn TS; Bae JM; Kim S; Lim DH; Kang WK; Kim KM; Pietrantonio F; Lee J
    Oncology; 2019; 97(1):38-43. PubMed ID: 31048579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.
    Yun S; Koh J; Nam SK; Kwak Y; Ahn SH; Do Park J; Kim HH; Kim WH; Lee HS
    Cancer Immunol Immunother; 2021 Feb; 70(2):431-441. PubMed ID: 32785776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts.
    Quaas A; Biesma HD; Wagner AD; Verheij M; van Berge Henegouwen MI; Schoemig-Markiefka B; Pamuk A; Zander T; Siemanowski J; Sikorska K; Egthuijsen JMP; Meershoek-Klein Kranenbarg EM; van de Velde CJH; Buettner R; Alakus H; Cats A; Ylstra B; van Laarhoven HWM; van Grieken NCT
    Eur J Cancer; 2022 Sep; 173():95-104. PubMed ID: 35863110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
    Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
    Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
    Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
    Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.
    Kim JW; Im SA; Kim MA; Cho HJ; Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Lee HJ; Kim TY; Yang HK; Kim WH; Bang YJ
    Int J Cancer; 2014 Jan; 134(1):72-80. PubMed ID: 23649938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer.
    An JY; Choi YY; Lee J; Hyung WJ; Kim KM; Noh SH; Choi MG; Cheong JH
    Cancer Res Treat; 2020 Oct; 52(4):1153-1161. PubMed ID: 32599987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
    Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.
    Wang Z; Cheng S; Yao Y; Liu S; Liu Z; Liu N; Jin Y; Zhang Y; Yin F; Han G; Zhang J; Wang Q; Yan D; Wang L; Lu H; Deng T; Ji Z; Gao H; Fang W; Zhang H; Chen Z; Zou J; Tang Y; Xu C; Li J; Qu H; Bao L; Cao B; Wang X; Xu T; Sun Y; Shen L; Peng Z; Li J
    Cancer Immunol Immunother; 2024 Jul; 73(9):182. PubMed ID: 38967817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
    Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
    Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.